Marlen Yessirkepov
Overview
Explore the profile of Marlen Yessirkepov including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
63
Citations
682
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Doskaliuk B, Zimba O, Yessirkepov M, Klishch I, Yatsyshyn R
J Korean Med Sci
. 2025 Feb;
40(7):e92.
PMID: 39995259
The rapid advancement of artificial intelligence (AI) has transformed various aspects of scientific research, including academic publishing and peer review. In recent years, AI tools such as large language models...
2.
Fedorchenko Y, Yessirkepov M, Doskaliuk B, Zaiats L, Mahmudov K
Rheumatol Int
. 2025 Feb;
45(3):46.
PMID: 39932596
Thyroid disease is a common comorbidity in inflammatory rheumatic diseases (IRDs). It complicates disease management and treatment of IRDs. The interplay between thyroid disfunction and IRDs is confounded by shared...
3.
Seiil B, Zimba O, Korkosz M, Bekaryssova D, Zhakipbekov K, Qumar A, et al.
J Korean Med Sci
. 2025 Feb;
40(4):e9.
PMID: 39901523
Background: This survey examined healthcare professionals' knowledge, views, and perceptions of the responsibilities and functions of Research Ethics Committees (RECs). The study aimed to analyze ethical principles and operational issues...
4.
Yessirkepov M, Fedorchenko Y, Zimba O, Mukanova U
Rheumatol Int
. 2024 Dec;
45(1):13.
PMID: 39739042
Platelet-rich plasma (PRP) has gained increasing recognition as a promising therapeutic agent in managing rheumatic diseases. Conventional treatments, including nonsteroidal anti-inflammatory drugs (NSAIDs), corticosteroids, and disease-modifying antirheumatic drugs (DMARDs), primarily...
5.
Bekaryssova D, Yessirkepov M, Imanbaeva A
Rheumatol Int
. 2024 Dec;
45(1):8.
PMID: 39733125
Chronic pain and restricted mobility, hallmark features of rheumatic diseases, substantially affect patients' quality of life, often resulting in physical disability and emotional distress. Given the long-term nature of these...
6.
Enhancing chronic disease management through physical activity and pedometry-based health monitoring
Fedorchenko Y, Zimba O, Sagtaganov Z, Yessirkepov M
Rheumatol Int
. 2024 Oct;
44(12):2737-2743.
PMID: 39460763
Physical activity (PA) is a vital component in the management of chronic diseases, including cardiovascular, metabolic, and musculoskeletal conditions. In rheumatic diseases (RDs) such as rheumatoid arthritis (RA), systemic lupus...
7.
Assylbek M, Zimba O, Yessirkepov M, Kocyigit B
Rheumatol Int
. 2024 Oct;
44(12):3063-3071.
PMID: 39460762
The COVID-19 pandemic has profoundly affected healthcare systems, particularly post-stroke rehabilitation centers. The elevated severity of strokes and delayed hospital admissions caused numerous hurdles to rehabilitation administration during the peri-pandemic...
8.
Permenov B, Zimba O, Yessirkepov M, Anartayeva M, Suigenbayev D, Kocyigit B
Rheumatol Int
. 2024 Oct;
44(12):2745-2756.
PMID: 39412573
Extracorporeal Membrane Oxygenation (ECMO) has become an essential lifesaving intervention for individuals with severe cardiovascular and respiratory failure. Its application is expanding across several therapeutic contexts, surpassing conventional indications. The...
9.
Fedorchenko Y, Zimba O, Gulov M, Yessirkepov M, Fedorchenko M
J Korean Med Sci
. 2024 Oct;
39(39):e299.
PMID: 39403752
Prior to the coronavirus disease 2019 (COVID-19) pandemic, Central Asia and Eastern Europe saw a significant rise in international medical student enrollment, driven by competitive tuition fees, prestigious institutions, and...
10.
Arshabayeva G, Qumar A, Yessirkepov M, Zimba O, Kocyigit B
J Korean Med Sci
. 2024 Oct;
39(38):e297.
PMID: 39376192
Nurses constitute nearly 50% of the worldwide health workforce, and the World Health Organisation has advocated for an enlargement of their roles to guarantee fair health care and address the...